Similar effects were observed in C57BL/6 mice treated with Panc02 (pancreatic cancer cell line), where CD47 mAb in combination with CTLA‐4 treatment inhibited tumour growth more profoundly than single treatment.86 Here, CD47 is linked to neoplasm.